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Through its specific receptor, the amphotropic murine leukemia virus (MLV) infects cells from many mammals, including
humans. We have previously demonstrated that levels of human amphotropic MLV receptor (pit2) mRNA varied considerably
in different human cell lines. Removal of phosphate from the culture medium led to increases in the amount of pit2 mRNA
and the quantity of a 71-kDa protein specifically recognized by antibodies against Pit2. To determine if the increases in pit2
mRNA and protein levels were due to a transcriptional effect, the pit2 promoter region was cloned. This region was
characterized and found to contain a functional TATA-less promoter that under our experimental conditions does not respond
to phosphate depletion. Instead, pit2 mRNA was found to be more stable in response to Pi depletion. These results suggest
that the increase in pit2 mRNA levels observed in response to Pi depletion occurs at a posttranscriptional level and is due
to enhanced mRNA stability. © 1998 Academic Press
INTRODUCTION
Because binding of the viral envelope glycoprotein to the
surface of the target cell is the initial step of retroviral
infection, cellular expression of the viral receptor is in many
cases the major determinant of tropism. The receptors for
several murine retroviruses have been identified and found
to belong to a group of related transporter molecules con-
taining characteristic multiple membrane-spanning do-
mains (Albritton et al., 1989; Kavanaugh et al., 1994; Miller et
al., 1994; Olah et al., 1994; van Zeijl et al., 1994; Wilson et al.,
1995). The receptor for the amphotropic murine leukemia
virus (MLV) is a widely expressed sodium/phosphate trans-
porter (Kavanaugh et al., 1994; Wilson et al., 1995). The
mRNA levels of this receptor increase in the absence of
inorganic phosphate (Pi) (Chien et al., 1997; Kavanaugh et
al., 1994), resulting in elevated receptor protein expression
(Chien et al., 1997). These findings have been used to
improve transduction protocols involving retrovirus vectors
pseudotyped with the amphotropic envelope (Bunnell et al.,
1995; Richardson and Bank, 1996).
In Escherichia coli, exogenous Pi levels regulate tran-
scription of genes involved in the transport and assimi-
lation of Pi (Makino et al., 1994). In some Streptomyces
species, exogenous Pi levels regulate, at the transcrip-
tional level, the biosynthesis of some antibiotics (Martin
et al, 1994). The role of Pi in the regulation of gene
expression in mammalian cells has not been clearly
established. Here we describe the molecular cloning
and partial characterization of the promoter region for the
human amphotropic MLV receptor gene (pit2, formerly
glvr-2). Our results show a functional promoter that does
not respond to Pi depletion. Instead, Pi depletion results
in the stabilization of pit2 mRNA, which in turn accounts
for the increased levels of pit2 mRNA and Pit2 protein
observed after Pi depletion.
MATERIALS AND METHODS
Cell lines and transfection conditions.
The human monocytic cell line U937 was cultured in
RPMI 1640 plus 25 mM Hepes (Mediatech cellgro,
Fisher, Pittsburgh, PA) supplemented with 10% fetal bo-
vine serum (FBS, Hyclone, Logan, UT), 2 mM L-glu-
tamine, 1 mM sodium pyruvate, 50 IU/ml penicillin, and
50 mg/ml streptomycin (Mediatech cellgro, Fisher). Cells
were maintained at 37°C in a humidified incubator with
5% CO2. Human osteosarcoma 143B cells (ATCC CRL
8303) were cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM, Mediatech cellgro; Fisher) supplemented
with 10% FBS, 50 IU/ml penicillin, and 50 mg/ml strepto-
mycin. Cells were maintained at 37°C in a humidified
incubator with 10% CO2. 143B cells were transfected in
Opti-MEM (GIBCO/BRL, Grand Island, NY) using Lipo-
fectamine (GIBCO/BRL) according to the manufacturer’s
conditions. For each transfection, 2 mg of reporter plas-
mid was cotransfected with 0.5 mg of pEQ176 (which
contains a b-galactosidase gene under the control of a
cytomegalovirus promoter) as an internal control for
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transfection efficiency. For induction experiments, Pi-free
DMEM (ICN, Costa Mesa, CA) was supplemented with
10% dialyzed FBS (GIBCO/BRL), and 0.1 mM MEM non-
essential amino acids (GIBCO/BRL). This medium was
further supplemented with 1 mM Pi as needed. For in-
duction experiments, 143B cells were transfected in
DMEM with or without 1 mM Pi using Lipofectamine. The
culture media and cells from each experiment were har-
vested 48 h after transfection and assayed for human
growth hormone (hGH) levels by using the HGH-TGES kit
(Nichols, San Juan Capistrano, CA); b-galactosidase ac-
tivity was determined as previously described (Sam-
brook et al., 1989).
Rapid amplification of cDNA ends (RACE), genomic
library screening, and nucleotide sequencing
The 59-end of the pit2 mRNA was obtained by using
the Amplifinder RACE kit (Clontech, Palo Alto, CA) ac-
cording to the manufacturer’s specifications. The tem-
plate in the amplification reactions was mRNA from CEM
cells (human T cell line). In addition to the 59 anchor
primer provided in the kit, the oligonucleotides 59-ggc-
cattttggaaagtgggtgccggg-39 (p2) and 59-ggctggacaaact-
gctagctgctgg-39 (p3), derived from the pit2 cDNA se-
quence, were used as 39 nested primers. The products of
the PCR amplifications were cloned into pCRII (Clontech)
and sequenced. Eighty-five basepairs of the resulting
RACE product (Fig. 2) were 32P-labeled by PCR (Mertz
and Rashtchian, 1994) and used to screen a human
genomic library (Lambda DASH II HUVEC library; Strat-
agene, La Jolla, CA). Filters were prehybridized in 53
SSC (13 SSC: 150 mM NaCl, 15 mM sodium citrate, pH
7), 53 Denhardt’s solution [13 Denhardt’s solution:
0.02% each of polyvinylpyrrolidone, Ficoll (Type 400,
Pharmacia), bovine serum albumin (Fraction V, Sigma)],
0.5% sodium dodecyl sulfate (SDS), and 100 mg/ml de-
natured salmon sperm DNA. Hybridization to the 32P-
labeled DNA probe was done at 60°C overnight in the
same solution without Denhardt’s. Filters were rinsed at
room temperature in 23 SSC, 0.1% SDS briefly and
washed at 37°C in 0.13 SSC, 0.5% SDS for 1 h, followed
by washing at 68°C in 0.13 SSC, 0.1% SDS for 1 h in a
shaking water bath with several changes. Filters were
exposed to Kodak XAR-5 film with intensifying screens at
270°C. Two overlapping DNA fragments (9-kb EcoRI–
EcoRI and 8-kb HindIII–HindIII) from a positive l clone
were isolated and subcloned into pBluescript II SK(1)
(Stratagene; pBS9kb and pBS8kb). Restriction analysis of
these two overlapping fragments gave rise to a continu-
ous 12-kb map (Fig. 1). A 1.2-kb SacI–SmaI fragment from
pBS9kb plasmid was subcloned into pBluescript II SK(1)
for sequencing (see Fig. 1 for sequencing strategy). Nu-
cleotide sequences were obtained from an autose-
quencer (Model 373, American Biosystems, Inc., Foster
City, CA) by using fluorescent dideoxy chain terminator
chemistry. Computer analysis for putative binding sites
for transcription factors was performed by using the
Signal Scan software (Prestridge, 1996).
Fluorescence in situ hybridization (FISH) analysis
FISH was performed essentially as described previ-
ously (Shapiro et al., 1993). The 9-kb EcoRI–EcoRI frag-
ment from the pit2 genomic clone (Fig. 1) was labeled
with digoxigenin–dUTP by nick translation to generate a
pit2-specific probe. This probe was visualized by stain-
ing with fluorescein-conjugated anti-digoxigenin anti-
bodies. Because the pit2 gene is located near the cen-
tromere (Garcia et al., 1991), a biotin-labeled probe
specific for the chromosome 8 centromere was also
included. This probe was detected with Texas Red-con-
jugated avidin.
RNase protection and start site analysis
Two antisense RNA probes were used in the RNA
protection analysis (RPA) (Fig. 3A). The first was obtained
from pBS141 and in addition to vector sequences it con-
tained the 141-bp (28 to 1133 bp relative to the tran-
scriptional start site) BspEI–BspEI fragment from the pit2
genomic clone ligated into pBluescript II SK(1). The
second, pCR233, contained a 233-bp cDNA product ob-
tained by RACE corresponding to bases 145 through
1150 of the first exon and 127 nt of the second exon
ligated into pCRII (Clontech). The probes were generated
by using T7 RNA polymerase (Maxiscript in vitro tran-
scription kit; Ambion, Austin, TX) and labeled with [32P]-
CTP (DuPont NEN, Boston, MA). Total RNA was isolated
from U937 cells by acid–phenol/guanidinium thiocyanate
extraction (Chomczynski and Sacchi, 1987) with RNA
STAT-60 (Tel-Test, Friendswood, TX) according to the
manufacturer’s instructions. The antisense probes were
hybridized to total cellular RNA (30 mg) by using the
HybSpeed RPA kit (Ambion, Austin, TX) according to the
manufacturer’s recommendations. Yeast RNA was in-
cluded so that the total amount of RNA in each sample
was 50 mg. After RNase digestion, samples were sepa-
rated on a 5% polyacrylamide/8 M urea gel. The gels
were dried and exposed overnight to Kodak XAR-5 film
with intensifying screens at 270°C. The transcriptional
start site was determined by RNA protection assays as
previously described (Nonkwelo et al,. 1995).
Analysis of promoter function
We used a well-characterized and extensively used
human growth hormone (hGH) reporter system (Selden
et al., 1986) to assay the activity of the pit2 promoter
region. Three overlapping portions of the putative pro-
moter were cloned into the promoterless reporter vector,
p0GH. The clone containing approximately 4.5 kb up-
stream of the start site, pGH-G2P(24.5 kb/116), was
constructed by using a two-step cloning procedure. First,
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the NdeI-HindIII fragment of p0GH was replaced with a
59 NdeI–HindIII fragment (approximately 3.5 kb) from the
pBS9kb genomic clone, yielding pGH3.5kb. Then, a 1-kb
HindIII–Eco47III fragment from pBS9kb was cloned into
the SalI–HindIII sites of pGH3.5kb, yielding pGH-G2P
(24.5 kb/116). The clones containing 2 and 1 kb of the
promoter region, pGH-G2P(22 kb/116) and pGH-
G2P(21 kb/116), were made by digesting pGH-
G2P(24.5 kb/116) with NdeI (59) and EagI or HindIII (39),
filling in the ends, and religating. pGH-G2P(36/116) was
constructed similarly by digesting pGH-G2P(24.5 kb/
116) with NdeI (59) and BspE1 (39). Another construct
including an additional 104 bp downstream of the start
site, pGH-G2P(24.5 kb/1120), contained the 4.5-kb
NdeI–EagI genomic fragment and was used for induction
experiments. Each of these plasmids was cotransfected
with pEQ176 (internal control) into 143B cells in the ab-
sence or presence of Pi as indicated above. Human
growth hormone assays were performed as indicated
above. Each data point was normalized for b-galactosi-
dase activity.
RNA stability studies
The stability of pit2 mRNA was determined as pre-
viously described (Chau et al., 1994). Briefly, 143B cells
were cultured in media with or without Pi for 40 h
before addition of actinomycin D (ActD, 10 mg/ml;
Sigma, St. Louis, MO). Total RNA was isolated from
cells harvested 0, 4, 8, and 12 h after addition of ActD.
The amount of pit2 mRNA was determined by Northern
blot analysis as follows: for each time point, 15 mg of
total RNA was fractionated in a 1.5% agarose/2.2 M
formaldehyde gel and blotted onto Nytran membranes
using a Turboblotter (Schleicher & Schuell, Keene,
NH). The filters were crosslinked by exposing them to
a UV transilluminator for 1 min (Ultra-Violet Product,
chromato-vue Model 0-63, San Gabriel, CA). The blots
were prehybridized at 68°C for 20 min in QuikHyb
solution (Stratagene, La Jolla, CA). The DNA probes
used were a 750-bp BamHI–EcoRI fragment derived
from the coding sequence of the pit2 cDNA from
pMalfGLVR-2 (Chien et al., 1997) and a 500-bp XbaI–
HindIII fragment from the human glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) cDNA clone
pSP64-GAPDH. GAPDH served as an internal control
for the amount of RNA loaded to each well. Hybridiza-
tion of the probes to the filters was done at 68°C for
1 h in QuikHyb solution containing 100 mg/ml dena-
tured salmon sperm DNA. Blots were briefly rinsed at
room temperature in 0.13 SSC and 0.1% SDS, then
washed in this solution at 68°C for 1 to 2 h with
several changes. Blots were exposed overnight to
Kodak XAR-5 film with intensifying screens at 270°C.
Radioactivity associated with each band was quanti-
tated by phosphorimaging (PhosphorImager Model
425F, Molecular Dynamics).
RESULTS
Cloning and sequencing of the pit2 promoter
To determine if the expression of the amphotropic
MLV receptor gene, pit2, is regulated by Pi at the
transcriptional level, we cloned the pit2 promoter re-
gion from a human genomic library. We first isolated 59
sequences not found in the pit2 cDNA (van Zeijl et al.,
1994) using the RACE procedure (Belyavasky et al.,
1989; Frohman et al., 1988) and then used this RACE
product to screen a human genomic library. A 12-kb
genomic fragment that hybridized to the RACE probe
was mapped by restriction analysis (Fig. 1). Sequence
analysis of a 1.2-kb fragment that hybridized to the
probe identified 113 bp identical to a portion of the 59
FIG. 1. (Top) Restriction map of a 12-kb genomic fragment containing the pit2 promoter. (Bottom) Sequencing strategy. Arrows below the enzyme
sites represent individual sequencing runs. The transcriptional start site is indicated by the arrow above the enzyme sites. B, BspEI; Bs, BssHII; E,
EagI; Hc, HincII; Hd, HindIII; K, KpnI; N, NdeI; RI, EcoRI; P, PstI; S, SmaI; Stu, StuI; *Stu, StuI site blocked by methylation.
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end of the RACE product (Fig. 2). Computer analysis of
the nucleotide sequence from this 1.2-kb fragment
identified 13 SP1 binding sites (Jones and Tjian, 1985),
2 LBP-1 sites (Jones et al., 1988), 3 ADR-1 sites (Eisen
et al., 1988), 1 GMCSF site (Nimer et al., 1990), and 1
CREB site (Boam et al., 1990) on the antisense strand.
A putative splice donor site was also identified at the
39-end of the sequence that hybridized to the RACE
probe (Fig. 2). FISH analysis of human chromosome
spreads with the pit2 genomic clones was used to
identify its localization in the genome. A total of 15
metaphase spreads of phytohemagglutinin-stimulated
peripheral blood lymphocytes were analyzed; 11 of
these cells specifically bound both a pit2 and a human
chromosome 8 centromere-specific probe. The geno-
mic pit2 probe hybridized to the short arm of human
chromosome 8 immediately above the centromere, at
position 8p11.2 (data not shown).
Structure of the 59 untranslated region of pit2
RNase protection assays were used to determine the
transcriptional start site and the structure of the 59 un-
translated region of pit2. When incubated with total RNA,
a 337-nt antisense 32P-labeled RNA probe generated
from a pit2 RACE product (Fig. 3A) resulted in a 233-nt
protected fragment (Fig. 3B, lane 5). Since the protected
fragment contained sequences both upstream and
downstream of the intron, this result confirmed the pres-
ence of an intron in the 59 untranslated region (Fig. 2).
FIG. 2. Nucleotide sequence of the pit2 promoter region. A 1.2-kb DNA fragment hybridizing to the RACE probe was sequenced in both directions
(Fig. 1). Putative transcription factor binding sites are underlined and indicated above the sequence. The transcriptional start site (11) is indicated.
The residue at the 59 end of the RACE sequence is indicated by a double underline. The 85-bp sequence contained in the RACE probe is indicated
in boldface. Intronic sequences are indicated in italics.
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Consistent with these results, a 215-nt antisense RNA
probe derived from the pit2 genomic fragment resulted in
a 133-nt protected fragment after hybridization to cellular
RNA (Fig. 3B, lane 2). This probe was also used to
determine the transcription start site of the promoter
which was found 37 bp upstream of the RACE product
(Fig. 2 and data not shown).
Functional analysis of promoter activity
To establish whether the isolated genomic fragment
contained a functional promoter, we used an hGH re-
porter gene assay (Selden et al., 1986). Fragments ex-
tending approximately 4.5, 2, or 1 kb upstream of the
transcriptional start site were tested for promoter activity.
All of these three fragments promoted expression of the
reporter hGH gene (Fig. 4). Interestingly, the 4.5-kb
genomic fragment produced approx. fourfold lower lev-
els of hGH than the 1-kb fragment (Fig. 4). These results
suggest that these genomic DNA clones contain a func-
tional promoter. In addition, they indicate the presence of
negative regulatory elements in the 24.5- to 21-kb re-
gion of the pit2 promoter.
Analysis of Pi depletion on pit2 promoter activity
We have previously reported that in human 143B cells
there is a reproducible induction of pit2 mRNA and pro-
tein levels in response to Pi depletion from the culture
medium (Chien et al., 1997). To determine if the activity of
the pit2 promoter was influenced by Pi, 143B cells were
cotransfected with the hGH reporter construct containing
the 4.5-kb pit2 promoter fragment extending to 1120 bp
and pEQ176 (as internal control). No significant differ-
ences were observed between the hGH levels of the
transfected cells cultured in the presence or absence of
Pi (Fig. 5). Similarly, the activity for the control TK pro-
moter was not affected by exogenous Pi levels (Fig. 5).
These results suggest that, under our experimental con-
ditions, the pit2 promoter does not respond to Pi deple-
FIG. 3. RNase protection assays. (A) Diagram of the antisense RNA probes. The pit2 sequences that are upstream of the start site (11) are indicated
in black, the noncoding exon sequences downstream of the start site are indicated as open boxes, and the intron sequences are indicated by hatched
boxes. The dashed lines represent vector sequences. The lengths of the undigested probes and the expected sizes for the protected fragments from
transcripts initiated at the start site (11) are also indicated. (B) RNase protection assays. The probe made from the genomic fragment (pBS141) is
partially protected, as indicated by a 133-nt band (lane 2). The cDNA-derived portion of the probe (pCR233) is fully protected (233 nt, lane 5). Lane
1, 32P-labeled HaeIII-digested fx174 DNA size markers (M). Addition of RNase, yeast, and total cellular RNA is indicated on the top for each sample.
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tion and that the induction of pit2 in 143B cells is not
likely to occur at the transcriptional level. It should be
noted that in contrast to the similar promoter activity
observed with or without Pi, under conditions of Pi de-
pletion pit2 mRNA and protein levels increase (Chien et
al., 1997; Kavanaugh et al., 1994; and below).
Pi depletion enhances pit2 mRNA stability
Because the increase in pit2 mRNA levels in response to
Pi removal could not be attributed to a transcriptional effect,
we determined if Pi depletion affects pit2 mRNA stability. To
compare the stability of pit2 mRNA in the presence or
absence of Pi we used the transcription inhibitor ActD as
previously described (Belasco and Brawerman, 1993). 143B
cells were cultured in the presence or absence of Pi for 40 h
and at this point ActD was added to the culture medium.
Total RNA was harvested at different times after the addi-
tion of ActD, and Northern blot analysis was used to deter-
mine the levels of pit2 mRNA. GAPDH was used as an
internal control for each time point. At Time 0 the amount of
pit2 mRNA was higher in the samples cultured in Pi-de-
pleted medium (Fig. 6A, compare lanes 1 and 5). This
observation is consistent with our previous results and
those of others (Chien et al., 1997; Kavanaugh et al., 1994).
A time course was then used to determine if Pi depletion
affected the stability of pit2 mRNA. As shown in Fig. 6B, pit2
mRNA levels decreased more rapidly in the presence of
FIG. 4. Assay of pit2 promoter activity. 143B cells were transfected
with different reporter plasmids containing the indicated pit2 promoter
truncations (in parentheses) relative to the start site. In all transfections
pEQ176, a b-galactosidase expression construct was included as an
internal control. Samples of culture supernatants and cell pellets were
harvested 48 h after transfection and then assayed for hGH levels by
radioimmunoassay and b-galactosidase activity by a colorimetric as-
say. Each data point was normalized for b-galactosidase activity and is
presented relative to the value obtained with the p0GH ‘‘empty’’ control
vector. The data shown represent the mean of triplicate transfections
from a representative experiment. Error bars show the 95% confidence
intervals (mean 6 2 standard errors).
FIG. 5. Effect of Pi on the activity of the pit2 promoter. 143B cells were cotransfected with the indicated hGH reporter plasmids and pEQ176 (internal
control) using Lipofectamine reagent. The culture media (with or without 1 mM Pi) and the cell pellets were harvested 48 h after transfection and
assayed for hGH or b-galactosidase levels. Each data point was normalized for b-galactosidase activity. The data shown represent the mean of
triplicate transfections from a representative experiment. Error bars show the 95% confidence intervals (mean 6 2 standard errors).
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phosphate suggesting a shorter half life. Extrapolation from
the data obtained indicates a doubling of the half life of the
pit2 mRNA in the absence of Pi (from 7 to 14 h). These
results suggest that an increase in the stability of pit2
mRNA is responsible for the higher levels of pit2 message
observed after removal of Pi from the culture medium.
DISCUSSION
The amphotropic MLV receptor is a sodium/phosphate
transporter (Kavanaugh et al., 1994) whose mRNA ex-
pression is induced in response to Pi depletion (Chien et
al., 1997; Kavanaugh et al., 1994). Based on this obser-
vation several groups have reported an increase in trans-
duction via amphotropic-pseudotyped retrovirus vectors
when cells are cultured in medium without Pi (Bunnell, et
al., 1995; Richardson and Bank, 1996). Of particular in-
terest was the correlation between increased pit2 mRNA
expression of fetal liver cells cultured in Pi-free medium
and their increased transduction efficiency (Richardson
and Bank, 1996). The observed increase in transduction
efficiency of cells cultured in Pi-depleted medium sug-
gested a concomitant increase in the expression levels
of both receptor mRNA and protein. We have recently
shown that induction of pit2 mRNA correlates with a
similar increase in the amount of Pit2 protein (Chien et
al., 1997). Together, these experiments confirm that cul-
ture of target cells in Pi-depleted medium results in an
increase in pit2 mRNA levels, an increase in Pit2 protein
levels, and an increase in transduction efficiency. How-
ever, as we have previously indicated, the increase in
pit2 mRNA levels varies between different cell types and
optimal conditions for transduction should be carefully
evaluated for each particular application.
In an effort to understand the molecular mechanisms
FIG. 6. Effect of Pi on the stability of pit2 mRNA. (A) 143B cells were cultured in the absence (lanes 1–4) or in the presence (lanes 5–8) of 1 mM
Pi for 40 h before ActD was added (10 mg/ml). Total RNA was harvested at 0, 4, 8, and 12 h after ActD treatment and the levels of pit2 mRNA detected
by Northern blot analysis. The data shown are from a representative experiment (n 5 3). (B) Comparison of the rates of pit2 mRNA decay in the
presence (triangles) or absence (squares) of 1 mM Pi. The levels of pit2 mRNA at 0 h post-ActD treatment were considered to be 100%. Each data
point represents the mean from four sets of individual values. Error bars show the 95% confidence intervals (mean 6 2 standard errors). The statistical
analysis of variance (ANOVA) confirmed that the difference between the two curves was highly significant (P 5 0.0001).
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regulating the expression of pit2, the promoter for this
gene was cloned from a human genomic library. Se-
quence analysis of the region upstream of the 59 end of
the RACE product used to clone the promoter indicated
a high GC content. The lack of RACE products that
extended to the start site of transcription is likely due to
secondary structure arising from the high GC content in
this region. Interestingly, the sequence analysis did not
reveal a putative TATA box near the transcription start
site. However, GC-rich promoters of other cellular genes
also lack TATA boxes (Chen et al., 1997; Fraizer et al.,
1994; Kawamoto, 1994; Mandrup et al., 1992; Patel et al.,
1986; Reynolds et al., 1984; Singer-Sam et al., 1984;
Tanaka et al., 1990; Valerio et al., 1985). Chromosome
mapping using pit2 genomic fragments located the gene
on the short arm of human chromosome 8. This result is
in agreement with our previous finding using somatic
cell hybrids, which placed the pit2 gene near the peri-
centromeric region of human chromosome 8 (Garcia et
al., 1991). The fine mapping of pit2 to human chromo-
some 8p11.2 confirms and extends the extensive homol-
ogy between the proximal portion of chromosome 8 of
humans and mice (Fasman et al., 1994). As indicated for
rapit2 (Lyu and Kozak, 1994), this information provides an
opportunity to more closely examine this region of hu-
man chromosome 8 and for future genetic analysis and
manipulations.
The clones identified from the genomic library showed
promoter activity comparable to that of the thymidine
kinase promoter used as control in our experiments.
Interestingly, the construct containing the longest up-
stream sequence (4.5 kb) had lower promoter activity
than the shorter one tested (1 kb). These results indi-
cated the presence of negative regulatory elements in
the 24.5- to 21-kb portion of the promoter region. To
explain the increase in receptor mRNA expression ob-
served upon Pi depletion we originally hypothesized an
effect at the level of promoter activity. The base for this
hypothesis was the previously characterized bacterial
phosphate transporter system (Makino et al., 1994). Be-
cause there was no difference in the activity of the pit2
promoter in response to Pi, we determined if the induc-
tion of pit2 mRNA could result from a posttranscriptional
effect. Indeed, our results indicate that the absence of
phosphate enhances the stability of pit2 mRNA. This
enhanced stability is likely to account, at least in part, for
the increase in pit2 mRNA levels observed after Pi re-
moval. Interestingly, the mRNA encoding the Na-depen-
dent phosphate transporter from opossum kidney cells
(NaPi-4) has also been found to be more stable in the
absence of Pi (Markovich et al., 1995). Consistent with
our results, these investigators did not observe a differ-
ence in the transcriptional activity of the NaPi-4 promoter
in the presence or absence of Pi. Instead they reported a
lower rate of mRNA decay. Together, our results and
those previously published by Markovich et al., (1995)
suggest the possibility of a common mechanism of post-
transcriptional regulation which might extend to other Pi
transporters. The most obvious example is the Pi trans-
porter that serves as receptor for the gibbon ape leuke-
mia virus (Olah et al., 1994). Interestingly, the expression
of the ecotropic MLV receptor which was identified as an
amino acid transporter is not regulated by its substrates.
It should be noted that Pi depletion is not likely to be the
only way in which pit2 expression is regulated and that
other mechanisms might be able to up- or down-regulate
receptor expression at the transcriptional level. How Pi
might alter the stability of specific mRNAs is a question
that will require further investigation but that is likely to
elucidate novel mechanisms controlling gene expres-
sion.
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